BRPI0509456A - implantes intravìtreos em conjunto com terapia fotodinámica para melhorar a visão - Google Patents

implantes intravìtreos em conjunto com terapia fotodinámica para melhorar a visão

Info

Publication number
BRPI0509456A
BRPI0509456A BRPI0509456-9A BRPI0509456A BRPI0509456A BR PI0509456 A BRPI0509456 A BR PI0509456A BR PI0509456 A BRPI0509456 A BR PI0509456A BR PI0509456 A BRPI0509456 A BR PI0509456A
Authority
BR
Brazil
Prior art keywords
eye
conjunction
photodynamic therapy
vision
improve vision
Prior art date
Application number
BRPI0509456-9A
Other languages
English (en)
Inventor
Scott M Whitcup
James A Burke
David V Weinberg
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/837,348 external-priority patent/US20050244466A1/en
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of BRPI0509456A publication Critical patent/BRPI0509456A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts, ocular implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Prostheses (AREA)

Abstract

"IMPLANTES INTRAVìTREOS EM CONJUNTO COM TERAPIA FOTODINáMICA PARA MELHORAR A VISãO". A presente invenção refere-se a um método para o tratamento de um estado ocular posterior para melhorar a visão. O método inclui as etapas de colocação no olho de um implante bioerodível compreendendo um componente antiinflamatório e um componente polimérico bioerodível, introdução de um agente fotoativo no olho e irradiação do olho com radiação eletromagnética, por exemplo, energia luminosa, para ativar o agente fotoativo no olho e tratar o estado ocular posterior, melhorando, dessa forma, a visão do paciente.
BRPI0509456-9A 2004-04-30 2005-04-27 implantes intravìtreos em conjunto com terapia fotodinámica para melhorar a visão BRPI0509456A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/837,348 US20050244466A1 (en) 2004-04-30 2004-04-30 Photodynamic therapy in conjunction with intraocular implants
US11/112,523 US20050244500A1 (en) 2004-04-30 2005-04-22 Intravitreal implants in conjuction with photodynamic therapy to improve vision
PCT/US2005/014201 WO2005110365A1 (en) 2004-04-30 2005-04-27 Intravitreal implants in conjunction with photodynamic therapy to improve vision

Publications (1)

Publication Number Publication Date
BRPI0509456A true BRPI0509456A (pt) 2007-09-04

Family

ID=34966870

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0509456-9A BRPI0509456A (pt) 2004-04-30 2005-04-27 implantes intravìtreos em conjunto com terapia fotodinámica para melhorar a visão

Country Status (10)

Country Link
US (1) US20050244500A1 (pt)
EP (1) EP1750664B1 (pt)
JP (1) JP2007535540A (pt)
AU (1) AU2005244213B2 (pt)
BR (1) BRPI0509456A (pt)
CA (1) CA2565249A1 (pt)
DE (1) DE602005015439D1 (pt)
DK (1) DK1750664T3 (pt)
ES (1) ES2327249T3 (pt)
WO (1) WO2005110365A1 (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7431710B2 (en) 2002-04-08 2008-10-07 Glaukos Corporation Ocular implants with anchors and methods thereof
NZ617083A (en) * 2003-08-27 2015-04-24 Ophthotech Corp Combination therapy for the treatment of ocular neovascular disorders
US8685435B2 (en) 2004-04-30 2014-04-01 Allergan, Inc. Extended release biodegradable ocular implants
US8142388B2 (en) * 2006-10-30 2012-03-27 Gomez Mario P Apparatus to facilitate removal of cataracts of from the eyes
US20100150911A1 (en) * 2007-02-14 2010-06-17 Opto Global Holdings Pty Ltd Methods and systems of treating age-related macular-degeneration
US10206813B2 (en) 2009-05-18 2019-02-19 Dose Medical Corporation Implants with controlled drug delivery features and methods of using same
US8349005B2 (en) 2011-01-03 2013-01-08 Masatoshi Murata Method for burying implant to choroid
US10245178B1 (en) 2011-06-07 2019-04-02 Glaukos Corporation Anterior chamber drug-eluting ocular implant
JP6100008B2 (ja) 2013-02-06 2017-03-22 正敏 村田 生体用インプラント
PT2956476T (pt) 2013-02-18 2020-02-21 Vegenics Pty Ltd Moléculas de ligação e usos destas
SG10201912985RA (en) 2013-07-12 2020-02-27 Ophthotech Corp Methods for treating or preventing ophthalmological conditions
AU2014348369B2 (en) * 2013-11-15 2020-04-02 Allergan, Inc. Methods of treatment of ocular conditions with a sustained drug delivery implant
EP3677229A1 (en) 2014-05-29 2020-07-08 Glaukos Corporation Implants with controlled drug delivery features
WO2016210346A1 (en) * 2015-06-24 2016-12-29 Healionics Corporation Injectable porous device for treatment of dry and wet age-related macular degeneration or diabetic retinopathy
CN106620893B (zh) 2015-07-23 2021-07-30 爱博诺德(北京)医疗科技股份有限公司 用于眼部疾病光治疗的材料
WO2017040853A1 (en) 2015-09-02 2017-03-09 Glaukos Corporation Drug delivery implants with bi-directional delivery capacity
WO2017053885A1 (en) 2015-09-25 2017-03-30 Glaukos Corporation Punctal implants with controlled drug delivery features and methods of using same
JP7003110B2 (ja) 2016-04-20 2022-01-20 ドーズ メディカル コーポレーション 生体吸収性眼球薬物送達デバイス
CN113101530B (zh) * 2021-04-14 2022-09-30 中国人民解放军陆军特色医学中心 一种通过无线充电激活玻璃体腔植入性发光二极管的系统

Family Cites Families (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) * 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
SE390255B (sv) * 1974-02-18 1976-12-13 N G Y Torphammar Upprullningsanordning foretredesvis for ett sekerhetsbelte i ett fordon
GB1478759A (en) * 1974-11-18 1977-07-06 Alza Corp Process for forming outlet passageways in pills using a laser
US4144317A (en) * 1975-05-30 1979-03-13 Alza Corporation Device consisting of copolymer having acetoxy groups for delivering drugs
US4063064A (en) * 1976-02-23 1977-12-13 Coherent Radiation Apparatus for tracking moving workpiece by a laser beam
US4285987A (en) * 1978-10-23 1981-08-25 Alza Corporation Process for manufacturing device with dispersion zone
US4200098A (en) * 1978-10-23 1980-04-29 Alza Corporation Osmotic system with distribution zone for dispensing beneficial agent
US4304765A (en) * 1980-10-14 1981-12-08 Alza Corporation Ocular insert housing steroid in two different therapeutic forms
US4327725A (en) * 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
JPS58126435U (ja) * 1982-02-19 1983-08-27 オリンパス光学工業株式会社 Ｔｔｌオ−トストロボ用絞り制御回路
US4649151A (en) * 1982-09-27 1987-03-10 Health Research, Inc. Drugs comprising porphyrins
US4521210A (en) * 1982-12-27 1985-06-04 Wong Vernon G Eye implant for relieving glaucoma, and device and method for use therewith
US4675338A (en) * 1984-07-18 1987-06-23 Nippon Petrochemicals Co., Ltd. Tetrapyrrole therapeutic agents
US4693885A (en) * 1984-07-18 1987-09-15 Nippon Petrochemicals Co., Ltd. Tetrapyrrole therapeutic agents
US4656186A (en) * 1985-04-30 1987-04-07 Nippon Petrochemicals Co., Ltd. Tetrapyrrole therapeutic agents
US4668506A (en) * 1985-08-16 1987-05-26 Bausch & Lomb Incorporated Sustained-release formulation containing and amino acid polymer
US4959217A (en) * 1986-05-22 1990-09-25 Syntex (U.S.A.) Inc. Delayed/sustained release of macromolecules
US4997652A (en) * 1987-12-22 1991-03-05 Visionex Biodegradable ocular implants
US4853224A (en) * 1987-12-22 1989-08-01 Visionex Biodegradable ocular implants
US5190966A (en) * 1988-07-06 1993-03-02 Health Research, Inc. Purified hematoporphyrin dimers and trimers useful in photodynamic therapy
US4968715A (en) * 1988-07-06 1990-11-06 Health Research, Inc. Use of purified hematoporphyrin trimers in photodynamic therapy
US5093349A (en) * 1988-07-20 1992-03-03 Health Research Inc. Photosensitizing agents
US5002962A (en) * 1988-07-20 1991-03-26 Health Research, Inc. Photosensitizing agents
US5198460A (en) * 1988-07-20 1993-03-30 Health Research Inc. Pyropheophorbides and their use in photodynamic therapy
US4935498A (en) * 1989-03-06 1990-06-19 Board Of Regents, The University Of Texas System Expanded porphyrins: large porphyrin-like tripyrroledimethine-derived macrocycles
US5457183A (en) * 1989-03-06 1995-10-10 Board Of Regents, The University Of Texas System Hydroxylated texaphyrins
US5171741A (en) * 1989-04-21 1992-12-15 Health Research, Inc. Bacteriochlorophyll-a derivatives useful in photodynamic therapy
US5173504A (en) * 1989-04-21 1992-12-22 Health Research, Inc. Bacteriochlorophyll-a derivatives useful in photodynamic therapy
US5503721A (en) * 1991-07-18 1996-04-02 Hri Research, Inc. Method for photoactivation
US5164188A (en) * 1989-11-22 1992-11-17 Visionex, Inc. Biodegradable ocular implants
US5075115A (en) * 1990-04-02 1991-12-24 Fmc Corporation Process for polymerizing poly(lactic acid)
US5232844A (en) * 1990-05-15 1993-08-03 New York Blood Center Photodynamic inactivation of viruses in cell-containing compositions
KR0185215B1 (ko) * 1990-11-30 1999-05-01 요시다 쇼오지 서방성 안구삽입용 약제
IT1263116B (it) * 1992-04-09 1996-07-30 Rotta Research Lab Derivati basici dell'acido glutammico ed acido aspartico, procedimento per la loro preparazione e loro uso farmaceutico
US5655832A (en) * 1992-04-16 1997-08-12 Tir Technologies, Inc. Multiple wavelength light processor
US5244914A (en) * 1992-04-27 1993-09-14 American Cyanamid Company Stable porfimer sodium compositions and methods for their manufacture
US6217869B1 (en) * 1992-06-09 2001-04-17 Neorx Corporation Pretargeting methods and compounds
WO1995003807A1 (en) * 1993-07-27 1995-02-09 The University Of Sydney Treatment of age-related macular degeneration
US5443505A (en) * 1993-11-15 1995-08-22 Oculex Pharmaceuticals, Inc. Biocompatible ocular implants
DE4403326C1 (de) * 1994-02-03 1995-06-22 Hans Reinhard Prof Dr Koch Intraokulare Linsenanordnung zur Astigmatismuskorrektur
US5798349A (en) * 1994-03-14 1998-08-25 The General Hospital Corporation Use of green porphyrins to treat neovasculature in the eye
US6270492B1 (en) * 1994-09-09 2001-08-07 Cardiofocus, Inc. Phototherapeutic apparatus with diffusive tip assembly
US5869079A (en) * 1995-06-02 1999-02-09 Oculex Pharmaceuticals, Inc. Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
US6369116B1 (en) * 1995-06-02 2002-04-09 Oculex Pharmaceuticals, Inc. Composition and method for treating glaucoma
JP2961074B2 (ja) * 1995-09-06 1999-10-12 明治製菓株式会社 光化学療法用の新生血管閉塞剤
US5913884A (en) * 1996-09-19 1999-06-22 The General Hospital Corporation Inhibition of fibrosis by photodynamic therapy
US6270749B1 (en) * 1996-12-11 2001-08-07 Pharmacyclics, Inc. Use of Texaphyrin in ocular diagnosis and therapy
US6274614B1 (en) * 1997-02-11 2001-08-14 Qlt Inc. Methods, compositions and articles for reducing or preventing the effects of inflammation
WO1999007418A2 (en) * 1997-08-11 1999-02-18 Allergan Sales, Inc. Sterile bioerodible implant device with improved biocompatability and method
ATE428345T1 (de) * 1998-07-09 2009-05-15 Curelight Medical Ltd Vorrichtung und verfahren zur wirkungsvollen hochenergetischen photodynamischen therapie von akne vulgaris und seborrhoe
US6290713B1 (en) * 1999-08-24 2001-09-18 Thomas A. Russell Flexible illuminators for phototherapy
US6317616B1 (en) * 1999-09-15 2001-11-13 Neil David Glossop Method and system to facilitate image guided surgery
US6331313B1 (en) * 1999-10-22 2001-12-18 Oculex Pharmaceticals, Inc. Controlled-release biocompatible ocular drug delivery implant devices and methods
US6443976B1 (en) * 1999-11-30 2002-09-03 Akorn, Inc. Methods for treating conditions and illnesses associated with abnormal vasculature
CA2714081C (en) * 2000-02-10 2013-08-06 Massachusetts Eye And Ear Infirmary Methods and compositions for treating conditions of the eye
NZ521360A (en) * 2000-03-24 2004-07-30 Novartis Ag Improved treatment of neovascularization
AU2002248284A1 (en) * 2000-11-01 2002-08-06 Allergan, Inc. Compositions for treatment of ocular neovascularization
US20030082183A1 (en) * 2000-11-01 2003-05-01 Wheeler Larry A. Methods and compositions for treatment of ocular neovascularization and neural injury
DE60114229T2 (de) * 2000-11-29 2006-07-06 Allergan, Inc., Irvine Verhinderung von transplantatabstossung im auge
AU2002233092A1 (en) * 2001-02-15 2002-08-28 Qlt Inc. Reduction or prevention of pdt related inflammation
EP1385452B1 (en) * 2001-07-23 2006-09-13 Alcon, Inc. Ophthalmic drug delivery device
US20030118657A1 (en) * 2001-12-04 2003-06-26 West Jennifer L. Treatment of disease states characterized by excessive or inappropriate angiogenesis
US6899717B2 (en) * 2002-09-18 2005-05-31 Allergan, Inc. Methods and apparatus for delivery of ocular implants
WO2004028477A2 (en) * 2002-09-29 2004-04-08 Surmodics, Inc. Methods for treatment and/or prevention of retinal disease
CN101035537A (zh) * 2004-10-01 2007-09-12 默克公司 治疗眼部疾病的组合物和方法

Also Published As

Publication number Publication date
ES2327249T3 (es) 2009-10-27
CA2565249A1 (en) 2005-11-24
EP1750664A1 (en) 2007-02-14
US20050244500A1 (en) 2005-11-03
EP1750664B1 (en) 2009-07-15
AU2005244213B2 (en) 2010-06-17
DK1750664T3 (da) 2009-11-02
DE602005015439D1 (de) 2009-08-27
WO2005110365A1 (en) 2005-11-24
AU2005244213A1 (en) 2005-11-24
JP2007535540A (ja) 2007-12-06

Similar Documents

Publication Publication Date Title
BRPI0509456A (pt) implantes intravìtreos em conjunto com terapia fotodinámica para melhorar a visão
AR037307A1 (es) Metodos para el tratamiento de enfermedades oculares neovasculares
WO2006116621A3 (en) Methods for treating eye conditions
WO2006015016A3 (en) Photodynamic therapy and compositions for treating ocular glaucoma
BRPI0502400A (pt) Telemetria transcutânea de baixa frequência para dispositivo médico implantado
US11925686B2 (en) Materials for phototherapies of ophthalmic diseases
CN101296676B (zh) 黄斑变性的治疗设备
NZ583375A (en) System and method for defining and controlling ltk and other surgical eye procedures to produce little or no stromal collagen shrinkage
KR20050062597A (ko) 포토바이오스티뮬레이션을 수행하기 위한 장치 및 방법
WO2008002796A8 (en) Optical material and method for modifying the refractive index
BR122015016901B8 (pt) implante de bioerosão para tratamento de uma condição médica do olho humano compreendendo dexametasona
ATE467439T1 (de) System und verfahren zur kontrolle und einstellung von interstitiellen photodynamischen lichttherapie-parametern
JP2013523273A5 (pt)
CN104853700A (zh) 用于照射眼睛的装置和方法
BRPI0414984A (pt) dispositivo de implante peniano, kit do mesmo, e, métodos para produzir um dispositivo de implante peniano e para implantar uma prótese peniana de um dispositivo de implante peniano no pênis de um paciente para o tratamento da impotência
TR201907062T4 (tr) Işın uygulama cihazı.
CN101822872A (zh) 一种眼近红外光治疗仪
Kwok et al. Flexible optical waveguides for uniform periscleral cross-linking
WO2006041744A3 (en) Low energy pdt for ocular disease
US11027144B2 (en) Laser therapy for at least one of grade III and grade IV capsular contracture
CN210872850U (zh) 瞳距调节机构以及便携式视力训练仪
EP3053553B1 (de) Vorrichtung zur Prävention von Achsenmyopie des Auges
CN204521168U (zh) 一种核黄素-紫外线巩膜交联法用交联器
CN104758119B (zh) 一种核黄素‑紫外线巩膜交联法用交联器
EP2316405A1 (en) Apparatus for stimulation of tissues, particularly for female erogenous zones

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE A 9A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2260 DE 29/04/2014.